Neem leaf glucosamine mediated immune stimulation was studied in male swiss albino mice. Mice were treated with three doses of Neem leaf glucosamine (266, 400 and 800 µg/30gm mouse, intraperitoneal injection) one dose per week for four weeks. At doses of 266, 400 and 800 µg/30gm mouse a significant increase in the Interleukin-2 in mice serum was observed when compared to the control group and also increase in relative organ weight of thymus was observed but there was mild increase on liver and kidney weights. Immune Stimulatory response of the Neem leaf glucosamine was also observed in the T-lymphocytes proliferation. Overall, Neem leaf glucosamine showed a stimulatory effect on immune functions in mice. The immunostimulatory effect of Neem leaf glucosamine as reported in this study will have special relevance for the prophylactic and therapeutic potential treatment of various infectious diseases and antitumor activity.
Introduction
Neem tree (Azadirachta indica A. Juss.) is a sacred gift of nature, mainly cultivated in Indian subcontinent [1] . Neem is an omnipotent tree. Neem is a member of the mahogany family, Meliaceae. Every part of this tree has been used as traditional Indian medicine for household remedy, against various human diseases [2] . In 1992, US National Academy of Science published a report entitled, 'Neem-a tree for solving global problem' [3] . The first recorded use of Neem is attributed to the ancient East Indian 'Harrappa Culture' which added the plant to dozens of health and beauty aids 4500 years ago.
Azadirachta indica A. juss (neem) is well known in India and its neighbouring countries for more than 2000 years as one of the most versatile medicinal plants. The rural Indian population chiefly use water-soluble components of neem leaf in their daily life for prevention and treatment of various ailments [4] . There are reports showing the effectiveness of these components in various diseases [5, 6] .
Neem leaf contains several valuable components such as terpenoids, azadirone and its derivatives are important [7] .
Numerous scientific reports validate the traditional uses of Neem in both the maintenance of general health and skin care. Practically every part of Azadirachta indica (leaves, bark, fruit, flowers, oil, and gum) have been reported to be associated with various remedial properties [8, 9] such as antimicrobial effects [10] , storage behaviour [11] , reduction of paracetamol-induced liver damage [12] , enhancer of hepatic glutathione and glutathione-dependent enzymes [13] , in vitro antiviral activity [14] , insecticidal activity [15] , antibacterial agent [16] .
Noting the strong manifestation of the immunomodulating activity reported in the literature of neem, it is proposed to embark upon a detailed characterization of the active compound present in aqueous extract of Neem leaf and immunopharmacological study of this phenomenon with a view of establishing its efficacy as a safe immune booster. This study will have special relevance for the prophylactic and therapeutic potential treatment of various infectious diseases.
In the present study, we have isolated the Neem leaf glucosamine from the aqueous extract of Neem leaf and investigated the characterization of Neem leaf glucosamine and immunomodulatory activity of Neem leaf glucosamine in swiss wistar albino mice.
Materials and Methods

Preparation of Neem leaf extracts by cold extraction
Neem (Azadirachta indica) is found widely in the Sungai Petani region, Malaysia.The plant leaves were separated from other parts washed and shade dried. Dried leaves were chopped into small pieces and made into coarse powder and passed through a 10-mesh sieve. Neem leaf extracts were prepared using 660 g of the air dried and powdered neem leaf material with various solvents of different polarity (hexane, chloroform, methanol, and water).
Isolation and structure elucidation of Neem leaf glucosamine
Aqueous neem leaf extract (21.23 g) was subjected to column chromatography. of the fractionated aqueous neem leaf extract (4.25 g) were subjected to HPLC to separate the compounds. Aqueous neem leaf extract was dissolved in acetonitrile/water (60:40) and the soluble compounds was concentrated and subjected to TLC and HPLC [17, 18] . The TLC mobile phase system was acetonitrile/water (6:4). TLC results showed only one spot before and after being treated with sulphuric acid and it was observed under visible light at 254nm. The Rf value observed was 0.75. The sample 0.1mg/1ml, injection volume 20µl was added to a Phenomenex5u(Luna) C18 column, 4.6 X 250mm with the flow rate of 0.5ml/min and the mode was isocratic. The detection wavelength was 215nm. Single high intensity peak was observed in the HPLC and it was collected. The yield of the isolated neem leaf compound was 150 mg.
Neem leaf glucosamine was isolated from the aqueous neem leaf extract by HPLC and structure elucidation was performed by NMR.
The isolated neem leaf compound were subjected to NMR for structure elucidation [19 & 20] . Male Swiss Wistar mice weighing 25-30g were used. Dry pellet diet and water were given ad libitum. Animals were maintained and treated according to the guidelines established by the Institutional Animal Care and Ethics Committee.
Chromatogram of
Acute Toxicity Studies
Acute toxicity was performed as per organization for economic co-operation for development (OECD) guideline 423 method [21] . Three groups of animals were selected (6 mice/group). Male Swiss Wistar mice were injected single dose of Neem leaf glucosamine by intraperitoneal route [22] . Animals are fasted 3 h prior to dosing (food was withheld for 3 h but not water). Following the period of fasting animals was weighed and test substance was administered orally at a dose of 1mg, 2mg, 4mg/30gm mouse. After the Neem leaf glucosamine administration, food was withheld 2 h in mice. Animals are observed individually after at least once during the first 30 minutes, periodically during the first 24 hrs, with special attention given during the first 4 hrs, and daily thereafter, for a total of 14 days.
Immunizations
Four groups of male swiss wistar mice were selected for the experiment. Group one served as a control (0.9% Phosphate Buffer Saline). Three groups of male swiss wistar mice were (10 mice/group) intraperitoneally injected with Neem leaf glucosamine at the dose of 266 µg/30 gm mouse, 400 µg/30 gm mouse & 800 µg/30 gm mouse weekly for 4 weeks [23] . The animal body weights were obtained weekly to determine the effects of Neem leaf glucosamine on body weight. At the end of the experimental period the blood samples of the mice were collected by terminal procedure cardiac puncture and the mice was sacrificed by cervical dislocation. The serum obtained from the centrifugation process was subjected for the measurement of the Interleukin-2 (IL-2) concentration by Enzyme linked immunosorbent assay (ELISA). Thymus, livers and kidneys were excised from the mice and weighed and was preserved in formalin for histopathological studies.
Enzyme linked immunosorbent assay (ELISA)
The RayBio® Mouse IL-2 ELISA (Enzyme-Linked Immunosorbent Assay) kit was used. It is an in vitro enzyme-linked immunosorbent assay for the quantitative measurement of mouse IL-2 in serum, plasma and cell culture supernatants [24] . This assay employs an antibody specific for mouse IL-2 coated on a 96-well plate. Standards and samples are pipetted into the wells and IL-2 present in a sample is bound to the wells by the immobilized antibody. The wells are washed and biotinylated anti-mouse IL-2 antibody is added. After washing away unbound biotinylated antibody, HRP-conjugated streptavidin is pipetted to the wells. The wells are again washed, a TMB substrate solution is added to the wells and color develops in proportion to the amount of IL-2 bound. The Stop Solution changes the color from blue to yellow, and the intensity of the color is measured at 450 nm.
Histopathological studies
Histopathological Studies of the thymus, liver and kidneys of the Neem leaf glucosamine treated mice groups (266µgm/30gm mouse, 400µgm/30gm mouse & 800µgm/30gm mouse) was carriedout.
Statistical Analysis
All data represents the mean ± standard deviation (SD). Significance of differences between the data obtained from different groups of mice was analyzed by two sample independent 't' test, one way analysis of Variance (one way -ANOVA) [25] , Post Hoc Test, Simple bar diagram and Multiple bar diagram. p˂ 0.05 was considered to indicate statistical significance.
Results
Neem leaf glucosamine did not induce drug related toxicity
Single dose of Neem leaf glucosamine was injected to three groups of male swiss wistar mice at a dose of 1mg, 2mg, 4mg/30gm mouse. Showed normal activity in alertness, touch response, light reflex, pain response, righting reflex, gripping strength, pinna and corneal reflex, pupil size, urination, salivation, skin colour, lacrimation. Tremors, convulsion, grooming and writhing are absent.
Neem leaf glucosamine is effective as an immune stimulant to enhance the interleukin-2 (IL-2) concentration in mice serum
Three groups of Male Swiss Wistar mice were immunized with Neem leaf glucosamine at the dose of 266 µg/30 gm mouse, 400 µg/30 gm mouse and 800 µg/30 gm mouse weekly for 4 weeks.
( Fig. 1 ; Table 1 and 2) show the IL-2 concentration in mice serum were significantly increased from the three different dose of the Neem leaf glucosamine (266 µgm/30gm mouse, 400 µgm/30gm mouse & 800 µgm/30gm mouse) treated group when compared to the control group. The increase in the dose of the Neem leaf glucosamine treated group significantly showed an increase in the Interleukin-2 (IL-2) concentration in mice serum when compared to the control group. Table 1 and 2: Neem leaf glucosamine auguments Interleukin-2 (IL-2) in mice serum. Four groups of mice (n=10 in each group). Three groups of mice were immunized weekly for 4 weeks with Neem leaf glucosamine at the dose of 266 µg/30 gm mouse, 400 µg/30 gm mouse and 800 µg/30 gm mouse. Serum was tested for the concentration of IL-2 by ELISA. p˂ 0.05, when Neem leaf glucosamine (266 µg/30 gm mouse, 400 µg/30 gm mouse and 800 µg/30 gm mouse) was compared with control. 
Neem leaf glucosamine causes T-lymphocytes proliferation
Histopathological Studies of the Thymus of the Neem leaf glucosamine treated groups (266µgm/30gm mouse, 400µgm/30gm mouse & 800µgm/30gm mouse) showed the proliferation of T-lymphocytes (Fig. 3 . B,C,D) when compared to the control group (Fig. 3. A) . This shows that the three different doses of the Neem leaf glucosamine treated group possess immunostimulating activity.
Histopathological Studies of the Liver and Kidneys of the control group and the Neem leaf glucosamine treated groups (266µgm/30gm mouse, 400µgm/30gm mouse & 800µgm/30gm mouse) did not show any pathological changes. This finding indicates that Neem leaf glucosamine does not cause any hepatic and renal damage in the above mentioned three dose levels.
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Discussion and Conclusion
We identified and characterized the active component of Aqueous Neem leaf extract that is responsible for immunostimulatory activity. Neem leaf glucosamine was found to be the active component that is responsible for immunostimulatory activity in swiss albino mice.
We investigated the acute toxicity of Neem leaf glucosamine in male swiss albino mice. From the acute toxicity studies it was observed that the administration of single dose of Neem leaf glucosamine did not induce drug related toxicity and mortality in the mice up to 4mg/30 g mouse intraperitoneally.
Next, we investigated, the potential of Neem leaf glucosamine as an immune stimulant by enhancing interleukin-2 (IL-2) concentration in mice serum and proliferation of T-lymphocytes. Neem leaf was selected due to proved non-toxicity of neem preparations during regular human consumption. Our ELISA results clearly suggest that Neem leaf glucosamine stimulate the immune system. IL-2 is a protein of 133 amino acids (15.4 kDa). It is produced mainly by T-cells expressing the surface antigen CD4 following cell activation by mitogens or allogens under physiological conditions. Genetically engineered IL-2 has frequent and important adverse effects. Toxic effects observed are systemic (fever, chills, malaise), hemodynamic (capillary leak syndrome, hypotension), cardiac (arrhythmia, infarction), renal (renal dysfunction), infectious (septicemia), cutaneous, hematologic, gastrointestinal, endocrinologic and metabolic [26] .
To overcome the genetically engineered IL-2 adverse effectes, we found that natural products such as Neem leaf glucosamine's increased IL-2 effect as reported in this study will have special relevance for the prophylactic and therapeutic potential treatment of various infectious diseases and anti-tumor activity for a variety of tumor cell types since it can supports the proliferation and clonal expansion of T-cells that specifically attack certain tumor types with very less adverse effects.
Thus, results of the present study clearly suggest that Neem leaf glucosamine isolated from the aqueous Neem leaf extract can serve as a potential immunostiumlant. The effect of Neem leaf glucosamine in treating cancer and infectious diseases such as dengue, HIV, H5N1 bird flu, viral hepatitis needs to be explored.
